Department of Molecular Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Biochem Genet. 2010 Feb;48(1-2):141-51. doi: 10.1007/s10528-009-9306-7. Epub 2009 Nov 22.
The FOXE1 gene was screened for mutations in a cohort of 34 unrelated patients with congenital hypothyroidism, 14 of whom had thyroid dysgenesis and 18 were normal (the thyroid status for 2 patients was unknown). The entire coding region of the FOXE1 gene was PCR-amplified, then analyzed using single-stranded conformational polymorphism, followed by confirmation by direct DNA sequencing. DNA sequencing analysis revealed a heterozygous A>G transition at nucleotide position 394 in one of the patients. The nucleotide transition changed asparagine to aspartate at codon 132 in the highly conserved region of the forkhead DNA binding domain of the FOXE1 gene. This mutation was not detected in a total of 104 normal healthy individuals screened. The binding ability of the mutant FOXE1 protein to the human thyroperoxidase (TPO) promoter was slightly reduced compared with the wild-type FOXE1. The mutation also caused a 5% loss of TPO transcriptional activity.
FOXE1 基因在 34 名无关联先天性甲状腺功能减退症患者的队列中进行了突变筛查,其中 14 名患者甲状腺发育不全,18 名患者正常(2 名患者的甲状腺状态未知)。FOXE1 基因的整个编码区进行了 PCR 扩增,然后进行单链构象多态性分析,随后通过直接 DNA 测序进行确认。DNA 测序分析显示,一名患者的核苷酸位置 394 处发生杂合性 A>G 转换。核苷酸转换使 FOXE1 基因 forkhead DNA 结合域高度保守区域的密码子 132 处的天冬酰胺变为天冬氨酸。在总共筛查的 104 名正常健康个体中未检测到该突变。与野生型 FOXE1 相比,突变型 FOXE1 蛋白与人类甲状腺过氧化物酶(TPO)启动子的结合能力略有降低。该突变还导致 TPO 转录活性降低 5%。